Neurotrophins and neurotrophin receptors in proliferative diabetic retinopathy

• Published in: PloS one 2013-06, Vol.8 (6), p.e65472-e65472
• Main Authors: Abu El-Asrar, Ahmed M, Mohammad, Ghulam, De Hertogh, Gert, Nawaz, Mohd Imtiaz, Van Den Eynde, Kathleen, Siddiquei, Mohammad Mairaj, Struyf, Sofie, Opdenakker, Ghislain, Geboes, Karel
• Format: Article
• Language: English
• Subjects: Analysis; Angiogenesis; Angiogenesis Inducing Agents - metabolism; Animals; Biology; Blotting, Western; Brain; Brain research; Brain-derived neurotrophic factor; Diabetes; Diabetes mellitus; Diabetic neuropathy; Diabetic retinopathy; Diabetic Retinopathy - metabolism; Diabetic Retinopathy - pathology; Endothelial cells; Endothelial Cells - metabolism; Endothelial Cells - pathology; Enzyme-linked immunosorbent assay; Enzymes; Eye (anatomy); Fibroblasts; Fibrosis; Histology; Humans; Immunohistochemistry; Immunology; Immunoprecipitation; Laboratories; Male; Medical research; Medical schools; Medicine; Membranes; Nerve growth factor; Nerve Growth Factors - metabolism; Neurotrophic factors; Neurotrophin 3; Neurotrophin 4; Neurotrophin receptors; Patients; Rats; Rats, Sprague-Dawley; Receptors; Receptors, Nerve Growth Factor - metabolism; Retina; Retinal Vessels - metabolism; Retinal Vessels - pathology; Retinopathy; Rodents; Shedding; Streptozocin; TrkA protein; TrkA receptors; TrkB receptors; Vascular endothelial growth factor; Vitreous Body - metabolism; Vitreous Body - pathology
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0065472

Neurotrophins (NTs) are emerging as important mediators of angiogenesis and fibrosis. We investigated the expression of the NTs nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4) and their receptors TrkA, TrkB, and TrkC in proliferative diabetic retinopathy (PDR). As a comparison, we examined the expression of NTs and their receptors in the retinas of diabetic rats. Vitreous samples from 16 PDR and 15 nondiabetic patients were studied by Western blot analysis and enzyme-linked immunosorbent assay (ELISA). Epiretinal membranes from 17 patients with PDR were studied by immunohistochemistry. Rats were made diabetic with a single high dose of streptozotocin and retinas of rats were examined by Western blot analysis. Western blot analysis revealed a significant increase in the expression of NT-3 and NT-4 and the shedding of receptors TrkA and TrkB in vitreous samples from PDR patients compared to nondiabetic controls, whereas NGF and BDNF and the receptor TrkC were not detected with the use of Western blot analysis and ELISA. In epiretinal membranes, vascular endothelial cells and myofibroblasts expressed NT-3 and the receptors TrkA, TrkB and TrkC in situ, whereas NT-4 was not detected. The expression levels of NT-3 and NT-4 and the receptors TrkA and TrkB, both in intact and solubilized forms, were upregulated in the retinas of diabetic rats, whereas the receptor TrkC was not detected. Co-immunoprecipitation studies revealed binding between NT-3 and the receptors TrkA and TrkB in the retinas of diabetic rats. Our findings in diabetic eyes from humans and rats suggest that the increased expression levels within the NT-3 and NT-4/Trk axis are associated with the progression of PDR.